Showing results (401-410 of 450) with videos related to
Sort By:
Pageof 45
Human Mutation|February 5, 2000
Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. OnlineV M De Benedetti, P Radice, B Pasini, et al.Proceedings of the National Academy of Sciences of the United States of America|July 21, 1999
The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle controlL Sard, P Accornero, S Tornielli, et al.Oncogene|February 20, 1997
Identification of Shc docking site on Ret tyrosine kinaseE Arighi, L Alberti, F Torriti, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytesA Mazzocchi, W J Storkus, C Traversari, et al.The Journal of Experimental Medicine|September 8, 1999
An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesionsA Anichini, A Molla, R Mortarini, et al.The Journal of Clinical Investigation|October 1, 1996
Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigenM J Maeurer, S M Gollin, D Martin, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapyL Rivoltini, D J Loftus, K Barracchini, et al.Oncogene|February 8, 2006
Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanomaM Sensi, G Nicolini, C Petti, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: relevance for epitope specific vaccination protocolsM A Player, K C Barracchini, T B Simonis, et al.Cancer Research|June 1, 1996
Aberrant FHIT transcripts in Merkel cell carcinomaG Sozzi, H Alder, S Tornielli, et al.Pageof 45